Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
94 hedge funds and large institutions have $384M invested in Taro Pharmaceutical Industries Ltd. in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 31 increasing their positions, 31 reducing their positions, and 17 closing their positions.
20% more capital invested
Capital invested by funds: $318M → $384M (+$65.2M)
0% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 31
7% less funds holding
Funds holding: 101 → 94 (-7)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KAM
Krensavage Asset Management
New York
|
+$28.7M |
| 2 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$3.99M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$3.8M |
| 4 |
Renaissance Technologies
New York
|
+$2.93M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$7.03M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$6.46M |
| 3 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
-$3.16M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.98M |
| 5 |
CM
Crestline Management
Fort Worth,
Texas
|
-$2.79M |
TARO Hedge Fund Activity: Q4 2019 in Review
94 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2019, worth a combined $384M — up 20% from $318M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of TARO and 10 opened new positions — a net loss of 7 holders — while 31 trimmed existing stakes and 31 added.
The largest buyer was Krensavage Asset Management, opening a new position worth an estimated $28.7M. The largest seller was Arrowstreet Capital, cutting an estimated $7.03M.
- 94 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2019, down from 101 in Q3 2019.
- Funds reported $384M of Taro Pharmaceutical Industries Ltd. stock for Q4 2019, up 20% quarter-over-quarter.
- 10 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2019 and 17 closed out, a net change of -7 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q4 2019 was Krensavage Asset Management, an estimated $28.7M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q4 2019 was Arrowstreet Capital, an estimated $7.03M sold.
Based on aggregated 13F filings for Q4 2019.